These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3054751)

  • 1. [Pharmacokinetics and tolerance of ceftriaxone after subcutaneous administration].
    Bricaire F; Castaing JL; Pocidalo JJ; Vilde JL
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):702-5. PubMed ID: 3054751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and fundamental studies on ceftriaxone (CTRX) against urinary tract infections].
    Nishio S; Yoshihara H
    Hinyokika Kiyo; 1988 May; 34(5):937-42. PubMed ID: 3177133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administration in adult volunteers.
    Harb G; Lebel F; Battikha J; Thackara JW
    Curr Med Res Opin; 2010 Feb; 26(2):279-88. PubMed ID: 19947907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral ofloxacin versus intramuscular ceftriaxone in antibiotic prophylaxis in transurethral prostate resection].
    Botto H; Butreau-Lemaire M; Levy S; Delval C
    Prog Urol; 1993; 3(4):569-75. PubMed ID: 8401617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and pharmacokinetics studies of ceftriaxone upon 2g once daily administration in respiratory tract infections].
    Ishioka S; Yamakido H; Inyaku K; Hasegawa K; Yamakido M; Akagawa T; Kuwabara M; Kodomari Y; Kawamoto M; Arita H
    Jpn J Antibiot; 1991 Jun; 44(6):605-13. PubMed ID: 1890721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
    Pizzarelli F; David S; Sala P; Icardi A; Casani A
    Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
    Welte T; Petermann W; Schürmann D; Bauer TT; Reimnitz P;
    Clin Infect Dis; 2005 Dec; 41(12):1697-705. PubMed ID: 16288390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Shortened antibiotic therapy of meningococcal meningitis: 5-day administration of ceftriaxone].
    Auvergnat JC; Le Tallec JY; Marchou B; Massip P; Carrière JP; Armengaud M
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):735-7. PubMed ID: 3054758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ceftriaxone after intravenous, intramuscular and subcutaneous administration to domestic cats.
    Albarellos GA; Kreil VE; Landoni MF
    J Vet Pharmacol Ther; 2007 Aug; 30(4):345-52. PubMed ID: 17610408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of ceftriaxone administered intravenously and intramuscularly to calves.
    Soback S; Ziv G
    Am J Vet Res; 1988 Apr; 49(4):535-8. PubMed ID: 3377315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ceftriaxone in patients undergoing continuous renal replacement therapy.
    Goto K; Sato Y; Yasuda N; Hidaka S; Suzuki Y; Tanaka R; Kaneko T; Nonoshita K; Itoh H
    J Basic Clin Physiol Pharmacol; 2016 Nov; 27(6):625-631. PubMed ID: 27497425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of azacitidine subcutaneous versus intravenous in patients with the myelodysplastic syndromes.
    Marcucci G; Silverman L; Eller M; Lintz L; Beach CL
    J Clin Pharmacol; 2005 May; 45(5):597-602. PubMed ID: 15831784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of ceftriaxone in intensive care].
    Bouget J; Garré M; Reyman JM; Guedes Y; Cartier F
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):706-10. PubMed ID: 3054752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of a novel recombinant human soluble thrombomodulin, ART-123.
    Moll S; Lindley C; Pescatore S; Morrison D; Tsuruta K; Mohri M; Serada M; Sata M; Shimizu H; Yamada K; White GC
    J Thromb Haemost; 2004 Oct; 2(10):1745-51. PubMed ID: 15456485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of ceftriaxone in severe infections in adults].
    Lacut JY; Dupon M; Quentin C; Brachet-Liermain A; Granger C; Echinard E
    Pathol Biol (Paris); 1986 May; 34(5):451-6. PubMed ID: 3534720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma and tissue concentration of ceftriaxone following a one-time i.v. dose of 2 g].
    Küttel JC; Petropoulos P; Crevoisier C
    Schweiz Med Wochenschr; 1988 May; 118(20):786-8. PubMed ID: 3387979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Penetration of ceftriaxone (1 or 2 gr intravenous) into mediastinal and cardiac tissues in man].
    Viviand X; Alaya M; Lokiec F; Ennabli K; Said R; Pecking M; Martin C
    Pathol Biol (Paris); 1995 Apr; 43(4):364-9. PubMed ID: 7567130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous and intravenous ceftriaxone administration in patients more than 75 years of age.
    Gauthier D; Schambach S; Crouzet J; Sirvain S; Fraisse T
    Med Mal Infect; 2014 Jun; 44(6):275-80. PubMed ID: 24932703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intramuscular versus subcutaneous erythropoietin for the treatment of anemia in CAPD patients.
    Abreo K; Lubom JA; Collier L; Fleming D; Work J
    Adv Perit Dial; 1994; 10():124-8. PubMed ID: 7999809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.